Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Lymphoma, Non-Hodgkin 3Lymphoma, Mantle-Cell 3Lymphoma, Follicular 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, T-Cell 2Leukemia, Myeloid, Acute 2Hodgkin Disease 2Burkitt Lymphoma 2Teratoma 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Plasmablastic Lymphoma 1Myelodysplastic Syndromes 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Monocytic, Acute 1Leukemia, Lymphoid 1Leukemia, Biphenotypic, Acute 1Hematologic Neoplasms 1HIV Infections 1Choriocarcinoma 1Carcinoma, Embryonal 1Anemia, Refractory, with Excess of Blasts 1

Interventions

venetoclax 44Specimen Handling 29Cytarabine 29Azacitidine 28fludarabine 24Biopsy 21Cyclophosphamide 14Injections 13Daunorubicin 13Busulfan 13decitabine and cedazuridine drug combination 12fludarabine phosphate 10Melphalan 9CPX-351 9Whole-Body Irradiation 8enasidenib 7Stem Cell Transplantation 7Mycophenolic Acid 7Idarubicin 7Gemtuzumab 7Decitabine 7revumenib 6ivosidenib 6gilteritinib 6X-Rays 6Thiotepa 6Tacrolimus 6Liposomes 6Granulocyte Colony-Stimulating Factor 6Mitoxantrone 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Leukemia, Myeloid, Acute × Peripheral Blood Stem Cell Transplantation × 30 days × Clear all
NCT07582172 2026-05-12

Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

City of Hope Medical Center

Phase 2 Not yet recruiting
35 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT03670966 2026-05-04

211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

Fred Hutchinson Cancer Center

Phase 1/2 Recruiting
30 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphoid, Leukemia, Monocytic, Acute, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡